Hans Glemstedt
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Hans Glemstedt
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hans Glemstedt tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INVESTOR AB | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| POZEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Chairman | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Karolinska Institutet | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chairman | |
Carnegie Investment Bank AB
 Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Investment Banks/Brokers | Director/Board Member Analyst-Equity | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
Investor AB (Investment Company)
 Investor AB (Investment Company) Financial ConglomeratesFinance Investor AB (Investment Company) (Investor-IC) is the investment division of Investor AB (STO: INVE-B; LSE: INU), a Swedish public company established in 1916 as the investment vehicle for the Wallenberg family, which still owns a significant part of the firm. Investor AB is an industrial holding company which manages private equity funds listed on the Swedish stock exchange. Headquartered in Stockholm, Investor-IC is a socially responsible investor which supports the OECD Guidelines for Multinational Enterprises, including anti-corruption and human rights. They are committed to the development of society at large and sponsor youth, education and entrepreneurship activities. | Financial Conglomerates | Chief Investment Officer Chief Investment Officer | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chairman | |
| ABLYNX | Biotechnology | Chairman | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman | |
Hi3G Denmark ApS
 Hi3G Denmark ApS Specialty TelecommunicationsCommunications Hi3G Denmark ApS provides wireless communication services. It also provides video communication, downloadable music and news. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| BioCrine AB | Director/Board Member | ||
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Synthélabo Scandinavia A/S | Corporate Officer/Principal | ||
Hi3G Access AB
 Hi3G Access AB Specialty TelecommunicationsCommunications Hi3G Access AB provides mobile communication services. It offers cellular phone services, paging services, wireless Internet access, and wireless video services. The company was founded in December 2000 and is headquartered in Stockholm, Sweden. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
| Astra Hässle AB | Chief Executive Officer | ||
HI3G Holdings AB
 HI3G Holdings AB Wireless TelecommunicationsCommunications HI3G Holdings AB engages in mobile and broadband services. The company is headquartered in Stockholm, Sweden. | Wireless Telecommunications | Director/Board Member Director/Board Member | |
Pfizer ApS
 Pfizer ApS Medical DistributorsDistribution Services Part of Pfizer Inc., Pfizer ApS is a Danish bio-pharmaceutical company. The company is based in Ballerup, Denmark. Pfizer is one of the world's leading bio-pharmaceutical companies. | Medical Distributors | Corporate Officer/Principal | |
SEKAB BioFuels & Chemicals AB
 SEKAB BioFuels & Chemicals AB Wholesale DistributorsDistribution Services SEKAB BioFuels & Chemicals AB manufactures and distributes green solutions in the field of chemicals and fuels. It imports, produces, refines, and sells ethanol as fuel. The firm develops an industrial structure that will enable the supply of knowledge and equipment for the production of cellulose based ethanol. The company was founded in 1985 and is headquartered in Domsjö, Sweden. | Wholesale Distributors | Director/Board Member | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Investor Relations Contact | |
| The Royal Bachelors' Club | Corporate Officer/Principal | ||
Med Universe AB
 Med Universe AB Internet Software/ServicesTechnology Services Med Universe AB provides online social networking services for doctors. Its services include software as a service, insights over time and multi-channel usage. The company was founded by Anna Omstedt Lindgren and Anna Norin in 2009 and is headquartered in Stockholm, Sweden. | Internet Software/Services | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal | ||
| Nicklasson Life Science AB | Corporate Officer/Principal | ||
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
| Sahlgrenska University | College/University | Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 33 |
| Danimarca | 7 |
| Regno Unito | 5 |
| Stati Uniti | 3 |
| Svizzera | 3 |
Settori
| Health Technology | 22 |
| Finance | 7 |
| Commercial Services | 7 |
| Consumer Services | 5 |
| Communications | 4 |
Posizioni
| Director/Board Member | 182 |
| Chairman | 67 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 30 |
Contatti più connessi
- Borsa valori
- Insiders
- Hans Glemstedt
- Connessioni Società
